期刊文献+

动态监测血小板水平与评估危重病患者的病情和预后 被引量:1

下载PDF
导出
摘要 目的通过动态监测血小板水平以评估危重病患者的病情和预后。方法对住院危重病患者每隔1天进行1次血液细胞分析,观察血小板水平的发展趋势,分析存活组和死亡组的血小板水平变化与危重病患者的病情和预后的关系。结果危重病患者存活组与死亡组血小板水平均有不同程度的下降。存活组血小板水平下降到一定程度后就逐渐回升到正常范围,而死亡组血小板水平的总趋势呈进行性下降。在诊断为危重病前3d,两组血小板水平差异无统计学意义(P>0.05),第7天后两组血小板水平差异有统计学意义(P<0.01)。结论血小板水平的变化可以反映危重病患者当前的治疗效果,动态监测血小板水平的发展趋势可以评估危重病患者的病情和预后。
出处 《国际检验医学杂志》 CAS 2008年第3期271-272,共2页 International Journal of Laboratory Medicine
  • 相关文献

参考文献8

  • 1黄顺伟,管向东,陈娟,欧阳彬,陈敏英.四种评分系统对重症脓毒症病人动态评分的比较[J].中国急救医学,2005,25(11):802-803. 被引量:10
  • 2梁建业.第3代危重患者病情评价系统——APACHE、SAPSⅡ和MPMⅡ[J].中国危重病急救医学,2000,12(4):249-253. 被引量:53
  • 3den-Boer S, de-Keiaer NF, de-Jonge E. Performance of prognostic models in critically ill cancer patients - a review [J]. Crit Care, 2005, 9(4): R458-R463.
  • 4Jacobs S, Zuleika M, Mphansa T. The Multiple Organ Dysfunction Score as a descriptor of patient outcome in septic shock compared with two other scoring systems [J]. Crit Care Med, 1999,
  • 5Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura [J]. N Engl J Med, 1998, 339(22): 1585-1594.
  • 6Furlan M, Robles R, Galbusera M, et al. von Willebrand factorcleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome [J]. N Engl J Med, 1998, 339(22): 1578-1584.
  • 7Pu Q, Wiel E, Corseaux D, et al. Beneficial effect of glycoprotein Ⅱb/Ⅲa inhibitor (AZ-1) on endothelium in Escherichia coil endotoxin-induced shock [J]. Crit Care Med, 2001, 29(6): 1181- 1188.
  • 8Vanderschueren S, De-Weerdt A, Malbrain M, et al. Thrombocytopenia and prognosis in intensive care [J]. Crit Care Med, 2000, 28(6): 1871-1876.

二级参考文献10

  • 1梁建业.危重病患者病情评定法——APACHE系统的研究进展[J].中国危重病急救医学,1996,8(1):52-56. 被引量:65
  • 2Knaus WA, Draper EA, Wagner DP, et al. APACHE Ⅱ: a severity of disease classification system[J] .Crit Care Med, 1985,13:818- 829.
  • 3Knaus WA, Wagner DP, Draper EA, et al. The APACHE Ⅲ prognostic system risk prediction of hospital mortality for critically ill hospitalized adults[J]. Chest, 1991,100:1619 - 1636.
  • 4Le Gall JR, Lemeshow S, Saulnier F. A new simplified acute physiology score( SAP Ⅱ )based on a European/North American multicenter study [ J ]. JAMA, 1993,270:2957 - 2963.
  • 5Marshall JC, Cook DJ, Christon N, et al. Multiple organ dysfnnction score: are reliable descriptor of a comp lex clinical outcome[J]. Crit Care Med, 1995,23,1638 - 1652.
  • 6Markgraf R, Deutschinoff G, Pientka L, et al. Comparison of acute physiology and chronic health evaluation Ⅱ and Ⅲ and simplified acute physiology score Ⅱ: a prospective cohort study evaluating these methods to predict outcome in a German interdisplinary intensive care uint[J].Crit Care Med,2000,28(1) :26 - 33.
  • 7Bone RC, Balk RA, Gerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovation therapies in sepsis [ J ].American Colleges of Chest Physician/Society of Critical Care Medicine Consensus Conference. Chest, 1992,101:1644 - 1655.
  • 8Jacobs S, Zulekia M, Mphansa T.The multiple organ dysfunction score as a descriptor of patient outcome in septic shock compared with two other scoring systems [ J ]. Crit Care Med, 1999,27: 741 - 743.
  • 9Buckley TA, Gomersall CD, Ramsay SJ. Validation of the multiple organ dysfunction (MOD) score in critically ill medical and surgical patients [J]. Intensive Care Med,2003,29(12) :2216 - 2222.
  • 10Taylor SL, Morgan DL, Denson KD, et al. Comparison of the Ranson,Glasgow, and APACHE Ⅱ scoring systems to a multiple organ system score in predicting patient outcome in pancreatitis[J]. Am J Surg,2005,189(2) :219- 222.

共引文献60

同被引文献15

  • 1Alexander Lowenthal,Benjamin Villareal Camacho,Shiri Lowenthal,Luz Natal-Hernandez,Walter Liszewski,Nancy K. Hills,Jeffrey R. Fineman,Harold S. Bernstein.Usefulness of B-Type Natriuretic Peptide and N-Terminal Pro-B-Type Natriuretic Peptide as Biomarkers for Heart Failure in Young Children With Single Ventricle Congenital Heart Disease[J]. The American Journal of Cardiology . 2012 (6)
  • 2Rodolfo Pizarro,Oscar O. Bazzino,Pablo F. Oberti,Mariano L. Falconi,Aníbal M. Arias,Juan G. Krauss,Arturo M. Cagide.Prospective Validation of the Prognostic Usefulness of B-Type Natriuretic Peptide in Asymptomatic Patients With Chronic Severe Aortic Regurgitation[J]. Journal of the American College of Cardiology . 2011 (16)
  • 3Mark E. Mikkelsen,Andrea N. Miltiades,David F. Gaieski,Munish Goyal,Barry D. Fuchs,Chirag V. Shah,Scarlett L. Bellamy,Jason D. Christie.Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock[J]. Critical Care Medicine . 2009 (5)
  • 4Jack E. Zimmerman,Andrew A. Kramer,Douglas S. McNair,Fern M. Malila.Acute Physiology and Chronic Health Evaluation (APACHE) IV: Hospital mortality assessment for today’s critically ill patients[J]. Critical Care Medicine . 2006 (5)
  • 5Farah A Husain,Matthew J Martin,Philip S Mullenix,Scott R Steele,David C Elliott.Serum lactate and base deficit as predictors of mortality and morbidity[J]. The American Journal of Surgery . 2003 (5)
  • 6Qian Pu,Eric Wiel,Delphine Corseaux,Régis Bordet,Michael A. Azrin,Michael D. Ezekowitz,Niels Lund,Brigitte Jude,Beno?t Vallet.Beneficial effect of glycoprotein IIb/IIIa inhibitor (AZ-1) on endothelium in Escherichia coli endotoxin-induced shock[J]. Critical Care Medicine . 2001 (6)
  • 7Steven Vanderschueren,Annick De Weerdt,Manu Malbrain,Dominique Vankersschaever,Eric Frans,Alexander Wilmer,Herman Bobbaers.Thrombocytopenia and prognosis in intensive care[J]. Critical Care Medicine . 2000 (6)
  • 8毛治尉,朱春霞.精氨酸血管加压素与心力衰竭研究的进展[J].心血管病学进展,2009,30(1):95-99. 被引量:7
  • 9王晓艳,杨侃,孙明,党瑜华.脑钠肽、和肽素和高敏C反应蛋白与急性冠状动脉综合征的相关性[J].中国动脉硬化杂志,2009,17(3):229-231. 被引量:33
  • 10杜玉哲.血浆脑钠肽对重度脓毒症患者诊断及预后的影响[J].实用临床医药杂志,2012,16(1):99-101. 被引量:9

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部